| Financial Year |
March 31 2021 |
| Monetary Funds |
13,708,051.20 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
1,240,340.36 |
| Advances to Suppliers |
256,578.76 |
| Other Receivables |
716,730.81 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
32,549.88 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
226,555,148.08 |
| Total Current Assets |
242,509,399.09 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
196,663,786.13 |
| Fixed Assetes |
26,333,329.41 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
3,652,622.09 |
| R&D expenses |
-- |
| Goodwill |
302,348.05 |
| Long-Term Deferred and Prepaid Expenses |
549,614.49 |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
3,990,900.00 |
| Sub-Total of Non-Current Assets |
231,992,600.17 |
| Total Assets |
474,501,999.26 |
| Short-Term Loans |
487,258,337.66 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
545,272.75 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
938,157.90 |
| Taxes Payable |
23,688,357.71 |
| Interest Payable |
135,496,808.14 |
| Dividend Payable |
-- |
| Other payables |
638,598,953.55 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
48,702,500.00 |
| Other Current Liabilities |
35,871.64 |
| Sub-Total of Current Liabilities |
1,200,303,623.06 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
1,770,946,411.51 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,772,429,927.91 |
| Total Liabilities |
2,972,733,550.97 |
| Paid-In Capital(Or Share Stock) |
1,056,070,400.00 |
| Capital Surplus |
1,738,875.78 |
| Surplus Reserve |
95,295,335.07 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-3,657,785,975.78 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
-2,498,231,551.71 |
| Owner's Equity（Stockholder's Equity） |
-2,498,231,551.71 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
474,501,999.26 |
